Bipolar Disorder: all 1,637 studies
Page 16 of 17. Open to participants first (258), then studies with results posted, then the rest; newest registration first within each.
- Lithium Versus Divalproex for Treating Pediatric Bipolar DisorderCompletedNCT00221429Phase 3
- An Open-Label Trial of Aripiprazole in Children and Adolescents With Bipolar DisorderCompletedNCT00221416Phase 3
- Low Field Magnetic Stimulation Treatment for Bipolar DepressionTerminatedNCT00217217Phase 3
- Taurine as an Anti-Manic Agent: A Double-Blind, Placebo-Controlled StudyCompletedNCT00217165Phase 2
- Efficacy and Safety of Aripiprazole in Patients With Schizophrenia or Bipolar DisorderCompletedNCT00216723
- The Safety and Efficacy of Risperidone as Adjunctive Therapy to Mood Stabilizers in the Long-term Treatment of Bipolar ManiaCompletedNCT00216554Phase 4
- Methylene Blue for Cognitive Dysfunction in Bipolar DisorderCompletedNCT00214877Phase 3
- Bipolar Disorder Research Study for Ages 12 and OlderCompletedNCT00211263Not applicable
- Depakote ER Therapy for Mania Comorbid With Substance AbuseCompletedNCT00208195Phase 4
- Abilify Therapy for Reducing Comorbid Substance AbuseCompletedNCT00208169Phase 4
- Six Month Trial of Lamotrigine vs. Sodium Valproate for Treatment of Mixed ManiaCompletedNCT00206778Phase 2
- Anti-Estrogens - A Potential Treatment for Bipolar Affective Disorder in Women?CompletedNCT00206544Phase 2
- Seroquel in Bipolar Depression Versus LithiumCompletedNCT00206141Phase 3
- Behavioral Processes Underlying Reward Processing in DepressionCompletedNCT00205933
- Carbamazepine Extended-Release for the Treatment of Bipolar DepressionCompletedNCT00203567Phase 4
- Divalproex ER vs. Risperidone for Bipolar Disorder With Comorbid Substance Use DisorderCompletedNCT00203528Phase 4
- Indicated Prevention of Psychotic Disorders With Low-dose LithiumCompletedNCT00202306Phase 4
- Comparison of Combination Olanzapine+Lithium or Chlorpromazine+Lithium in Treatment of First Manic Episode With Psychotic FeaturesCompletedNCT00202293Phase 4
- Safety And Efficacy Study Of Depakote ER To Treat Pediatric Bipolar DisorderCompletedNCT00199966Phase 4
- Aripiprazole Treatment of Bipolar DepressionCompletedNCT00198198Phase 4
- A Double-Blind, Placebo-Controlled Study of Galantamine to Improve Cognitive Dysfunction in Bipolar DisorderCompletedNCT00195845Phase 4
- Evaluate the Safety of Depakote Extended Release Tablets in the Treatment of Mania Associated With Bipolar Disorder in Children and AdolescentsCompletedNCT00195767Phase 3
- Pilot Study Evaluating the Safety and Efficacy of Open-Label OlanzapineTerminatedNCT00194064Phase 3
- Aripiprazole in Late Life Bipolar DisorderCompletedNCT00194038Phase 4
- Tryptophan Depletion in Acute ManiaCompletedNCT00192725Not applicable
- AIMHI NT Relapse Prevention TrialStatus unknownNCT00192582Not applicable
- Optimal Length of Treatment Continuation With Olanzapine After Remission of Manic or Mixed EpisodeCompletedNCT00191997Phase 4
- Bipolar Depression Study: Bipolar Depression Assessment Study on Treatment ResponseCompletedNCT00191399Phase 4
- Olanzapine Plus Carbamazepine in the Treatment of Bipolar I ManiaCompletedNCT00190892Phase 4
- Psychoeducation Versus Cognitive-Behavioral Therapy in Bipolar DisorderStatus unknownNCT00188838Not applicable
- Venlafaxine Versus Lamotrigine in the Treatment of Bipolar I/II DepressionCompletedNCT00188643Phase 4
- Transcranial Magnetic Stimulation in Bipolar DepressionCompletedNCT00186758Phase 4
- The Immune System and Psychiatric DisordersCompletedNCT00184418
- Understanding Treatment Adherence Among Individuals With Rapid Cycling Bipolar DisorderCompletedNCT00183703
- Determining the Safety and Effectiveness of Olanzapine in Children and AdolescentsTerminatedNCT00183612Not applicable
- Understanding Treatment Adherence Among Individuals With Bipolar DisorderCompletedNCT00183495
- Reproductive Function and Mood in Women With Bipolar DisorderCompletedNCT00183352
- Concerta in the Treatment of ADHD in Youth and Adults With Bipolar DisorderCompletedNCT00181987Phase 4
- Risperidone Versus Olanzapine for Mania in Preschool Children 4 to 6 Years of Age With Bipolar DisorderCompletedNCT00181935Phase 4
- Ziprasidone for the Treatment of Mania in Children and Adolescents With Bipolar DisorderCompletedNCT00181922Phase 4
- Bupropion SR for Major Depression and Depression NOS in Children and Adolescents With Bipolar DisorderTerminatedNCT00181896Phase 4
- Equetro for the Treatment of Mania in Children Ages 6-12 With Bipolar DisorderCompletedNCT00181870Phase 4
- Spectroscopy in Children and Adolescents With Bipolar DisorderCompletedNCT00181831
- Aripiprazole for the Treatment of Mania in Children and Adolescents With Bipolar DisorderCompletedNCT00181779Phase 4
- Study of Depakote ER for the Treatment of Mania in Children Ages 6-12 With Bipolar DisorderCompletedNCT00181727Phase 4
- Galantamine-CR and Cognitive Dysfunction in Bipolar DisorderCompletedNCT00181636Not applicable
- Effects of Risperidone and Olanzapine on Patients With Schizophrenia, Schizoaffective Disorder, Major Depression or Bipolar DisorderCompletedNCT00179062Not applicable
- Evaluation of QTc Interval by Continuous Holter ECG Recording in Antipsychotic Drug-treated Patients With SchizophreniaCompletedNCT00178958Not applicable
- Improving Outcome in Schizophrenia Through Identification of Genetic Risk FactorsCompletedNCT00178932Not applicable
- Treatment of Geriatric Bipolar Mood Disorders: A Pilot StudyCompletedNCT00177567Phase 4
- Health Care Management and Rehabilitation Skills Training for Treating Serious Mental Illness in Older PeopleCompletedNCT00169052Not applicable
- A Study of Risperidone Monotherapy in Bipolar AnxietyCompletedNCT00167479Phase 4
- Early Recovery Adherence Therapy for Bipolar AlcoholicsCompletedNCT00167323Not applicable
- 3-week Study of Asenapine, Olanzapine and Placebo for Treatment of Bipolar Mania (P07009)CompletedNCT00159796Phase 3
- 3-Week Study of Asenapine, Olanzapine and Placebo for Treatment of Bipolar Mania (P07008)CompletedNCT00159744Phase 3
- Effects of Psycho-education of Patients With Bipolar DisorderCompletedNCT00159562Not applicable
- Triiodothyronine (T3) Supplementation in the Treatment of Bipolar and Unipolar Depression.CompletedNCT00158990Phase 3
- Escitalopram as a Mood Stabilizer for Bipolar II DisorderCompletedNCT00156325Phase 2
- The Efficacy and Safety of Oral Oxcarbazepine 300-1200 mg/Day as Adjuvant Therapy in the Treatment of Bipolar Disorder I or II This Study is Not Being Conducted in the United States.CompletedNCT00154323Phase 4
- Safety of SPD417 Combined With Other Psychotropic Medications in the Treatment of Bipolar I DisorderCompletedNCT00150605Phase 3
- Efficacy and Safety of SPD417 in Treatment of Manic Symptoms in Adults With Bipolar I DisorderCompletedNCT00150553Phase 3
- 9 Week Extension Study of Asenapine and Olanzapine in Treatment of Mania (P07007)(COMPLETED)CompletedNCT00143182Phase 3
- Valnoctamide in ManiaCompletedNCT00140179Phase 3
- Progressively Decreasing Titration Schedules of Bifeprunox in Subjects With Schizophrenia or Bipolar DisorderCompletedNCT00139919Phase 2
- Open Label Extension Study of Licarbazepine in the Treatment of Manic Episodes of Bipolar I DisorderCompletedNCT00139594Phase 4
- Seroquel in Acute Mania: Study to Investigate if Valproate Add-On Therapy is Superior to Quetiapine Monotherapy in Acutely Manic PatientsTerminatedNCT00139074Phase 4
- Study Evaluating Bifeprunox in Bipolar DepressionCompletedNCT00134459Phase 3
- SOLMANIA - Comparison of Valproate-Amisulpride and Valproate-Haloperidol in Bipolar I PatientsCompletedNCT00126009Phase 2
- Seroquel in Bipolar Depression Versus SSRICompletedNCT00119652Phase 3
- Aripiprazole in Children and Adolescents With Bipolar Disorder and Attention Deficit Hyperactivity Disorder (ADHD)CompletedNCT00116259Not applicable
- Dopamine Receptor Imaging in Mood DisordersCompletedNCT00116077
- Olanzapine Treated Adolescents With Schizophrenia or Bipolar I DisorderCompletedNCT00113594Phase 3
- Study of Licarbazepine in the Treatment of Manic Episodes of Bipolar DisorderCompletedNCT00107939Phase 3
- Study of Licarbazepine in the Treatment of Manic Episodes of Bipolar DisorderCompletedNCT00107926Phase 3
- An Evaluation of the Safety and Efficacy of Memantine in Patients With Acute Mania Associated With Bipolar I DisorderCompletedNCT00106405Phase 2
- Psychiatric Advance Directives for Improved Mental Health CareCompletedNCT00105794Not applicable
- Study of Licarbazepine in the Treatment of Manic Episodes of Bipolar DisorderCompletedNCT00099229Phase 3
- Study of Aripiprazole in Patients With Acute Bipolar ManiaCompletedNCT00097266Phase 3
- Study Measuring Differences in Cognition Due to Sedative Effects of Risperidone and Quetiapine in Stable Bipolar I OutpatientsCompletedNCT00097032Phase 3
- Aripiprazole in Patients With Acute ManiaCompletedNCT00095511Phase 3
- A Study of Effectiveness and Safety of Risperdal CONSTA Added to Usual Treatment in Patients With Bipolar Disorder Who Have Frequent Mood Episodes.CompletedNCT00094926Phase 3
- Olanzapine vs. Comparator and Placebo in the Treatment of Patients With Bipolar I DisorderCompletedNCT00094549Phase 4
- Quetiapine Fumarate (SEROQUEL) Compared to Placebo in the Treatment of Children & Adolescents With Bipolar I ManiaCompletedNCT00090311Phase 3
- Controlled Study of the Use of Quetiapine Fumarate in the Treatment of Patients With Bipolar DepressionCompletedNCT00083954Phase 3
- Efficacy and Safety of Seroquel Plus Mood Stabilizer in the Maintenance of Bipolar I DisorderCompletedNCT00081380Phase 3
- Study of Aripiprazole in Patients With Bipolar I Disorder With a Major Depression EpisodeCompletedNCT00080314Phase 3
- Study to Determine the Effectiveness of Risperidone in Bipolar Disorder in Children and AdolescentsCompletedNCT00076115Phase 3
- Acute Treatment of Bipolar II DepressionCompletedNCT00074776Phase 3
- Acupuncture as a Supplemental Treatment for Bipolar DepressionCompletedNCT00071669Phase 2
- Depakote Monotherapy, Olanzapine Monotherapy, and Combination Therapy of Depakote Plus Olanzapine in Stable Subjects During the Maintenance Phase of Bipolar IllnessTerminatedNCT00071253Phase 4
- Bipolar Study in Adults at Least 18 Years of AgeCompletedNCT00067938Phase 4
- An Outpatient Study of the Effectiveness and Safety of Depakote ER in the Treatment of Mania/Bipolar Disorder in Children and AdolescentsCompletedNCT00067262Phase 3
- An Inpatient Study of the Effectiveness and Safety of Depakote ER in the Treatment of Mania/Bipolar DisorderCompletedNCT00060905Phase 3
- Safety and Efficacy Trial of the Use of Quetiapine Fumarate (SEROQUEL®) in the Treatment of Patients With Bipolar DepressionCompletedNCT00060489Phase 3
- Improving Antipsychotic Adherence Among Patients With Serious Mental IllnessCompletedNCT00057135Not applicable
- Bipolar Disorder Study for Men and WomenCompletedNCT00056277Phase 3
- Cholinergic Modulation of Condition and Emotion in Mood Disorders: Functional Neuroimaging StudiesTerminatedNCT00055575Phase 2
- Brain Imaging in DepressionCompletedNCT00050700
- Olanzapine Versus Placebo in the Treatment of Mania in Adolescents With Bipolar I DisorderCompletedNCT00050206Phase 4
- Treatment and Outcome of Early Onset Bipolar DisorderCompletedNCT00048802Phase 4